Patents by Inventor Ae Guk Kim

Ae Guk Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7485326
    Abstract: A microemulsion composition comprising biphenyldimethyldicarboxylate (BDD) and silybin or a derivative thereof, or a <i>Carduus marianus</i> extract containing silybin and derivatives thereof, as active ingredients; a co-surfactant; a surfactant; and an oil provides a synergistic therapeutic effect for liver diseases due to the complementary work of the two kinds of active ingredients having different working mechanisms without any adverse side effect or an antagonism, and high <i>in vivo</i> bioavailabilities of both of the active ingredients, when orally administered.
    Type: Grant
    Filed: October 21, 2004
    Date of Patent: February 3, 2009
    Assignee: Hanmi Pharm Co., Ltd.
    Inventors: Jong Soo Woo, Si Young Jung, Ae Guk Kim
  • Publication number: 20060233842
    Abstract: A microemulsion composition comprising biphenyldimethyldicarboxylate (DDB), a co-surfactant, a surfactant and an oil provides an improved stability and a high in vivo bioavailability of biphenyldimethyldicarboxylate when orally administered.
    Type: Application
    Filed: November 29, 2003
    Publication date: October 19, 2006
    Inventors: Jong-Soo Wood, Won-Tae Jung, Ae-Guk Kim, Tae-Sook Yoo, Moon-Soo Kim, Min-Sik Hwang
  • Publication number: 20060062810
    Abstract: A microemulsion concentrate comprising a water-insoluble anti-cold drug, a surfactant and an oil, which is prepared by a method comprising: (a) dissolving the water-insoluble anti-cold drug in a co-surfactant to obtain a homogeneous drug solution; (b) adding the surfactant and the oil in the drug solution to obtain a microemulsion pre-concentrate; and (c) removing the co-surfactant from the pre-concentrate, contains emulsified drug microparticles which are stable toward pH change and therefore, provides improved bioavaiability of the drug when orally administered.
    Type: Application
    Filed: November 7, 2003
    Publication date: March 23, 2006
    Inventors: Jong-Soo Woo, Ae-Guk Kim